ArticleJournal of clinical pathology2005
Expression of prostate specific antigen in male breast cancer.
Article in Journal of clinical pathology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 37 citations in OpenAlex.
- Utilization of NKX3.1 and P501S to distinguish primary breast carcinoma from metastatic prostatic adenocarcinoma in male patients.Virchows Archiv : an international journal of pathology · 2026Article
- Cancer of Unknown Primary in the Molecular Era.Trends in cancer · 2021Review
- Review
- Metachronous or synchronous male breast and prostate cancers a duality to lookout for.F1000Research · 2018Article
- Metastatic Breast Carcinoma to the Prostate Gland.Case reports in oncological medicine · 2016Article
- Reconnoitring the status of prostate specific antigen and its role in women.Indian journal of clinical biochemistry : IJCB · 2015Review
- Comparison of different prostatic markers in lymph node and distant metastases of prostate cancer.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2015Article
- Molecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues.BioMed research international · 2013Review
- Prostate-specific antigen and hormone receptor expression in male and female breast carcinoma.Diagnostic pathology · 2010Article
- The histological diagnosis of metastases to the breast from extramammary malignancies.Journal of clinical pathology · 2007Review
- Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma.Diagnostic pathology · 2007Article
- The effective management of biochemical recurrence in patients with prostate cancer.Reviews in urology · 2005Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Male breast cancer is uncommon, accounting for less than 1% of all breast cancers. Carcinoma metastatic to the male breast is also unusual, with metastatic prostatic carcinoma being among the most common primary sites from which such tumours derive. Metastatic prostatic cancer and primary breast cancer may be histologically indistinguishable without immunohistochemistry because both often infiltrate with a cribriform architecture. Distinguishing between primary and metastatic disease within the breast is important because the treatment options for each are radically different. Following a case in which metastatic prostatic disease was initially wrongly diagnosed as primary breast cancer, a small series of male breast cancers was examined for expression of prostate specific antigen (PSA) and prostatic acid phosphatase to assess the usefulness of these markers in making this distinction. Focal expression of PSA was found in one of 11 cases of male breast cancer. These results indicate that PSA should be used with caution in this context.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.